Literature DB >> 24627486

Molecular dissection of phage endolysin: an interdomain interaction confers host specificity in Lysin A of Mycobacterium phage D29.

Amol Arunrao Pohane1, Himanshu Joshi, Vikas Jain.   

Abstract

Mycobacterium tuberculosis has always been recognized as one of the most successful pathogens. Bacteriophages that attack and kill mycobacteria offer an alternate mechanism for the curtailment of this bacterium. Upon infection, mycobacteriophages produce lysins that catalyze cell wall peptidoglycan hydrolysis and mycolic acid layer breakdown of the host resulting in bacterial cell rupture and virus release. The ability to lyse bacterial cells make lysins extremely significant. We report here a detailed molecular dissection of the function and regulation of mycobacteriophage D29 Lysin A. Several truncated versions of Lysin A were constructed, and their activities were analyzed by zymography and by expressing them in both Escherichia coli and Mycobacterium smegmatis. Our experiments establish that Lysin A harbors two catalytically active domains, both of which show E. coli cell lysis upon their expression exclusively in the periplasmic space. However, the expression of only one of these domains and the full-length Lysin A caused M. smegmatis cell lysis. Interestingly, full-length protein remained inactive in E. coli periplasm. Our data suggest that the inactivity is ensued by a C-terminal domain that interacts with the N-terminal domain. This interaction was affirmed by surface plasmon resonance. Our experiments also demonstrate that the C-terminal domain of Lysin A selectively binds to M. tuberculosis and M. smegmatis peptidoglycans. Our methodology of studying E. coli cell lysis by Lysin A and its truncations after expressing these proteins in the bacterial periplasm with the help of signal peptide paves the way for a large scale identification and analysis of such proteins obtained from other bacteriophages.

Entities:  

Keywords:  Bacteriophage; Mycobacteria; Peptidoglycan; Periplasmic Expression; Protein-Protein Interactions; Surface Plasmon Resonance (SPR); Zymography

Mesh:

Substances:

Year:  2014        PMID: 24627486      PMCID: PMC4002114          DOI: 10.1074/jbc.M113.529594

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Bacteriophage endolysins--current state of research and applications.

Authors:  Martin J Loessner
Journal:  Curr Opin Microbiol       Date:  2005-08       Impact factor: 7.934

Review 2.  LysM, a widely distributed protein motif for binding to (peptido)glycans.

Authors:  Girbe Buist; Anton Steen; Jan Kok; Oscar P Kuipers
Journal:  Mol Microbiol       Date:  2008-05       Impact factor: 3.501

Review 3.  The next generation of bacteriophage therapy.

Authors:  Timothy K Lu; Michael S Koeris
Journal:  Curr Opin Microbiol       Date:  2011-08-23       Impact factor: 7.934

4.  Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.

Authors:  J M Loeffler; D Nelson; V A Fischetti
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

5.  Mycobacteriophage Ms6 LysA: a peptidoglycan amidase and a useful analytical tool.

Authors:  Sebabrata Mahapatra; Charles Piechota; Filipa Gil; Yufang Ma; Hairong Huang; Michael S Scherman; Victoria Jones; Martin S Pavelka; Jose Moniz-Pereira; Madalena Pimentel; Michael R McNeil; Dean C Crick
Journal:  Appl Environ Microbiol       Date:  2012-11-16       Impact factor: 4.792

6.  Structure and lytic activity of a Bacillus anthracis prophage endolysin.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert C Liddington
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

Review 7.  Extensively drug-resistant tuberculosis: current challenges and threats.

Authors:  Amita Jain; Rajesh Mondal
Journal:  FEMS Immunol Med Microbiol       Date:  2008-05-08

8.  Genome structure of mycobacteriophage D29: implications for phage evolution.

Authors:  M E Ford; G J Sarkis; A E Belanger; R W Hendrix; G F Hatfull
Journal:  J Mol Biol       Date:  1998-05-29       Impact factor: 5.469

9.  Periplasmic expression and recovery of human interferon gamma in Escherichia coli.

Authors:  Victor E Balderas Hernández; Luz M T Paz Maldonado; Emilio Medina Rivero; Ana P Barba de la Rosa; Juan F Jiménez-Bremont; Leandro G Ordoñez Acevedo; Antonio De León Rodríguez
Journal:  Protein Expr Purif       Date:  2008-02-05       Impact factor: 1.650

10.  Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.

Authors:  Maarten Walmagh; Yves Briers; Silvio Branco dos Santos; Joana Azeredo; Rob Lavigne
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

View more
  15 in total

1.  A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.

Authors:  Yang Yang; Zhen Liu; Xiaoqin He; Juanjuan Yang; Jing Wu; Hailong Yang; Min Li; Qian Qian; Ren Lai; Wei Xu; Lin Wei
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

2.  Insights into the Physiology and Metabolism of a Mycobacterial Cell in an Energy-Compromised State.

Authors:  Varsha Patil; Vikas Jain
Journal:  J Bacteriol       Date:  2019-09-06       Impact factor: 3.490

3.  Molecular dissection of a dedicated formaldehyde dehydrogenase from Mycobacterium smegmatis.

Authors:  Saloni Rajesh Wani; Vikas Jain
Journal:  Protein Sci       Date:  2021-12-18       Impact factor: 6.725

4.  Decoding the molecular properties of mycobacteriophage D29 Holin provides insights into Holin engineering.

Authors:  Varun Rakeshbhai Bavda; Aditi Yadav; Vikas Jain
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

5.  Methylotrophy in Mycobacteria: Dissection of the Methanol Metabolism Pathway in Mycobacterium smegmatis.

Authors:  Abhishek Anil Dubey; Saloni Rajesh Wani; Vikas Jain
Journal:  J Bacteriol       Date:  2018-08-10       Impact factor: 3.490

6.  Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability.

Authors:  Qiming Li; Mingliang Zhou; Xiangyu Fan; Jianlong Yan; Weimin Li; Jianping Xie
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

Review 7.  Mycobacteriophage Lysis Enzymes: Targeting the Mycobacterial Cell Envelope.

Authors:  Maria João Catalão; Madalena Pimentel
Journal:  Viruses       Date:  2018-08-14       Impact factor: 5.048

Review 8.  Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.

Authors:  Carlos São-José
Journal:  Antibiotics (Basel)       Date:  2018-03-22

9.  Separation of Mycobacterium smegmatis From a Mixed Culture Using the Cell Wall Binding Domain of D29 Mycobacteriophage Endolysin.

Authors:  Gokul Nair; Vikas Jain
Journal:  Front Microbiol       Date:  2020-06-05       Impact factor: 6.064

10.  Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1.

Authors:  Meng-Jiun Lai; Chih-Chin Liu; Shinn-Jong Jiang; Po-Chi Soo; Meng-Hsuan Tu; Jen-Jyh Lee; Ying-Huei Chen; Kai-Chih Chang
Journal:  Molecules       Date:  2015-10-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.